04Apr/13

Anti-HIV Antibodies May Spur AIDS Vaccine Development – TIME


TIME

Anti-HIV Antibodies May Spur AIDS Vaccine Development
TIME
From the moment of infection, the immune system goes on alert and immediately generates antibodies designed to attach to and destroy HIV. And for the first few weeks, these antibodies are successful, eliminating all but a few viruses that remain hidden
Antibodies ‘map’ to vaccine for AIDS foundThe Japan Times
Breakthrough Reported in Creating Antibodies to Fight HIV/AIDSLatinos Post
Findings on ‘Broadly Neutralizing Antibodies‘ May Be Key to HIV VaccineAIDSmeds.com HIV/AIDS Treatment News
Bloomberg –Nature.com –Counsel & Heal
all 38 news articles »
04Apr/13

Multiple Sklerose: Daclizumab HYP halbiert die Wahrscheinlichkeit von Schüben – Informationsdienst Wissenschaft (Pressemitteilung)

Multiple Sklerose: Daclizumab HYP halbiert die Wahrscheinlichkeit von Schüben
Informationsdienst Wissenschaft (Pressemitteilung)
Patienten mit einer schubförmig remittierenden Multiplen Sklerose profitieren von einer Behandlung mit dem monoklonalen Antikörper Daclizumab HYP (high-yield process). Dies ergab die heute im The Lancet online veröffentlichte SELECT-Studie.
Erfolg versprechend: Neues Medikament gegen Multiple Skleroseinnovations report

all 4 news articles »

03Apr/13

Path to HIV Seen in Study of Patient's Antibodies – Bloomberg


BBC News

Path to HIV Seen in Study of Patient’s Antibodies
Bloomberg
Blood samples from the person were used to monitor the AIDS virus as it mutated to evade immune system antibodies. While HIV almost always wins that battle, scientists after two years of testing the man found he was among the 20 percent of patients who
HIV: Roadmaps to a vaccineNature.com
Scientists find antibody “roadmap” to AIDS vaccineTimes of India
Duke researchers hone in on HIV vaccineDuke Chronicle
Wall Street Journal –Scientist –The Guardian Nigeria
all 22 news articles »